ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,226Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 106

$1.74M Total Retail Price of All Prescriptions

Rank: 3 out of 106

1,060 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,060 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

18% of this provider’s 1,060 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 14,139 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 59%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $178 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,001 515 S3 1 9
LISINOPRIL 810 399 2 13
SIMVASTATIN 787 484 3 14
FUROSEMIDE 745 418 4 7
OMEPRAZOLE 715 387 5 10
METFORMIN HCL 531 271 6 23
SPIRIVA 522 281 7 1
LEVOTHYROXINE SODIUM 465 284 8 17
ADVAIR DISKUS 444 238 9 2
PROAIR HFA 435 177 10 3
CLONIDINE HCL 383 203 11 41
AMLODIPINE BESYLATE 372 205 12 19
NEXIUM 353 120 13 28
SYMBICORT 340 156 14 4
WARFARIN SODIUM 324 220 15 21
GABAPENTIN 316 129 16 27
ATORVASTATIN CALCIUM 298 146 17 30
PREDNISONE 285 203 18 5
HYDROCHLOROTHIAZIDE 278 181 19 25
CARVEDILOL 264 177 20 49
POTASSIUM CHLORIDE 259 184 21 24
METOPROLOL TARTRATE 259 147 21 16
CIPROFLOXACIN HCL 242 158 23 48
SINGULAIR 238 162 24 11
SERTRALINE HCL 227 95 25 35
CITALOPRAM HBR 209 106 26 31
MIRTAZAPINE 209 157 26 60
ZOLPIDEM TARTRATE 205 142 28 22
VENTOLIN HFA 202 94 29 6
ETODOLAC 197 80 30 109
ATENOLOL 194 112 31 54
AZITHROMYCIN 190 115 32 8
LOSARTAN POTASSIUM 188 97 33 34
CLOPIDOGREL 188 124 33 61
CRESTOR 186 69 35 53
IBUPROFEN 182 56 36 112
RANITIDINE HCL 179 70 37 54
ROPINIROLE HCL 178 79 38 39
PRAVASTATIN SODIUM 175 111 39 33
MELOXICAM 173 101 40 46
RISPERIDONE 169 77 41 71
DIGOXIN 169 136 41 59
ESCITALOPRAM OXALATE 168 141 43 68
QUETIAPINE FUMARATE 154 58 44 91
DIVALPROEX SODIUM 147 88 45 94
RAMIPRIL 146 100 46 105
CYCLOBENZAPRINE HCL 146 31 R 46 92
PANTOPRAZOLE SODIUM 143 109 48 37
DONEPEZIL HCL 143 129 48 47
PLAVIX 141 95 50 78
LEVOFLOXACIN 141 85 50 20
MONTELUKAST SODIUM 140 93 52 26
METOPROLOL SUCCINATE 139 76 53 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 53 54 127
BENZTROPINE MESYLATE 135 22 R 55 128
PAROXETINE HCL 132 51 56 69
DIOVAN 130 54 57 85
TRAZODONE HCL 129 50 58 51
PHENYTOIN SODIUM EXTENDED 125 50 59 114
CEFUROXIME 122 69 60 106
CARISOPRODOL 121 12 R 61 50
NAMENDA 119 112 62 58
LANTUS 119 49 62 74
TRAMADOL HCL 119 64 62 116
OLANZAPINE 118 40 65 135
INSULIN SYRINGE 118 53 65 83
PREMARIN 114 56 R 67 138
GLIPIZIDE 114 70 67 115
METHYLPREDNISOLONE 113 69 69 98
AMOX TR-POTASSIUM CLAVULANATE 112 62 70 74
FLUTICASONE PROPIONATE 111 51 71 18
OXYCODONE-ACETAMINOPHEN 110 56 S2 72 96
COMBIVENT 108 78 73 12
FENTANYL 108 50 S2 73 111
HYDROXYZINE PAMOATE 104 12 R 75 141
NAPROXEN 99 28 76 120
THEOPHYLLINE ANHYDROUS 94 69 77 15
ESTRADIOL 94 45 R 77 148
CELEBREX 92 64 79 108
TRICOR 92 18 79 121
POLYETHYLENE GLYCOL 3350 87 53 81 118
JANUVIA 87 61 81 102
PROMETHAZINE HCL 86 26 R 83 82
ONGLYZA 86 48 83 154
AMOXICILLIN 85 52 85 77
ALLOPURINOL 84 56 86 62
CEPHALEXIN 84 56 86 123
GLIMEPIRIDE 83 72 88 117
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 44 88 29
METOCLOPRAMIDE HCL 83 47 88 56
ABILIFY 82 21 91 156
FLUCONAZOLE 79 40 92 129
LOSARTAN-HYDROCHLOROTHIAZIDE 78 47 93 121
ONDANSETRON HCL 77 29 94 158
BUSPIRONE HCL 75 49 95 93
DIVALPROEX SODIUM ER 75 13 95 162
CYMBALTA 74 30 97 89
NOVOLIN R 73 40 98 163
TRIAMTERENE-HCTZ 73 40 98 163
DOXAZOSIN MESYLATE 71 27 100 98
LYRICA 71 15 100 100
IPRATROPIUM-ALBUTEROL 70 64 102 103
KLOR-CON M20 70 36 102 64
LOVASTATIN 68 56 104 126
OXYCODONE HCL-ACETAMINOPHEN 65 45 S2 105 106
AMITRIPTYLINE HCL 64 41 R 106 95
CLOTRIMAZOLE-BETAMETHASONE 63 55 107 168
TAMSULOSIN HCL 62 50 108 52
MECLIZINE HCL 61 31 109 132
CLARITHROMYCIN 60 39 110 172
DOXYCYCLINE HYCLATE 59 34 111 44
SUCRALFATE 59 55 111 174
LITHIUM CARBONATE 57 0 113 176
NYSTATIN 56 31 114 73
HYDRALAZINE HCL 56 38 114 65
MINOXIDIL 56 35 114 179
LEXAPRO 53 45 117 183
LEVEMIR 53 30 117 183
LACTULOSE 52 38 119 187
METFORMIN HCL ER 52 22 119 187
FLUOXETINE HCL 51 21 121 142
LEVETIRACETAM 50 21 122 137
KLOR-CON 10 50 24 122 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.